Search

Fortuna Haviv

from Deerfield, IL
Age ~84
Get Report
Also known as:
Haviv Fortuna
Phone and address:
1125 Oxford Rd, Bannockburn, IL 60015
(847) 948-1135
Related to:
Shalom Habib, 81Avi Haviv
Connected to:
Galila Haviv, 50Naama S Haviv, 46Sharon Haviv, 66Eli Haviza, 33Felix E Havkin, 42Connie D Havlak, 68Joe F Havlak, 92William L Havlena, 84Anika Havlicek, 66Annabelle Havlicek, 70

Fortuna Haviv Phones & Addresses

  • 1125 Oxford Rd, Deerfield, IL 60015 (847) 948-1135
  • Wheeling, IL
  • Vernon Hills, IL

Publications

Us Patents

3€²,3€²-N-Bis-Desmethyl-3€²-N-Cycloalkyl Erythromycin Derivatives As Lhrh Antagonists

View page
US Patent:
6387885, May 14, 2002
Filed:
Aug 26, 1998
Appl. No.:
09/140157
Inventors:
Christopher R. Dalton - Mundelein IL
Milan Bruncko - Lake Bluff IL
Michele A. Kaminski - Beach Park IL
Lisa M. Frey - Mundelein IL
Daryl R. Sauer - Trevor WI
Fortuna Haviv - Deerfield IL
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
A61K 3170
US Classification:
514 29, 536 72, 536 74, 536 185
Abstract:
Disclosed are 3â,3â-N-bis-desmethyl-3â-N-cycloalkyl-6-O-methyl-11-deoxy-11,12-cyclic carbamate erythromycin A derivatives which are antagonists of lutenizing hormone-releasing hormone (LHRH). Also disclosed are pharmaceutical compositions comprising the compounds, to methods of using the compounds and to the process of making the same.

Peptide Antiangiogenic Drugs

View page
US Patent:
6716963, Apr 6, 2004
Filed:
Nov 22, 1999
Appl. No.:
09/447226
Inventors:
Jack Henkin - Highland Park IL
Fortuna Haviv - Deerfield IL
Michael F. Bradley - Chicago IL
Douglas M. Kalvin - Buffalo Grove IL
Andrew J. Schneider - Gurnee IL
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
C07K 700
US Classification:
530328, 514 15
Abstract:
Peptides having the formula: wherein A is selected from hydrogen or an acyl group; A is a hydroxyl group or an amino acid amide; and A , A , A , A , A , A , A , A , and A are amino acyl residues as defined herein.

Peptides Having Antiangiogenic Activity

View page
US Patent:
6753408, Jun 22, 2004
Filed:
Nov 22, 2000
Appl. No.:
09/718591
Inventors:
Fortuna Haviv - Deerfield IL, 60015
Jack Henkin - Highland Park IL, 60035
Michael F. Bradley - Chicago IL, 60613
Douglas M. Kalvin - Buffalo Grove IL, 60089
Andrew J. Schneider - Gurnee IL, 60031
International Classification:
C07K 700
US Classification:
530328, 514 15
Abstract:
Peptides of formula (I) are useful for inhibiting angiogenesis. Also disclosed are angiogenesis-inhibiting compositions and methods of inhibiting angiogenesis in a mammal.

Peptide Antiangiogenic Drugs

View page
US Patent:
6774211, Aug 10, 2004
Filed:
Apr 11, 2001
Appl. No.:
09/833196
Inventors:
Jack Henkin - Highland Park IL
Fortuna Haviv - Deerfield IL
Michael F. Bradley - Wadsworth IL
Douglas M. Kalvin - Buffalo Grove IL
Andrew J. Schneider - Gurnee IL
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
C07K 700
US Classification:
530328, 514 15
Abstract:
Peptides having the formula: wherein A is selected from hydrogen or an acyl group; A is a hydroxyl group or an amino acid amide; and A , A , A , A , A , A , A , A , and A are amino acyl residues as defined herein.

N-Alkylated Peptides Having Antiangiogenic Activity

View page
US Patent:
6777535, Aug 17, 2004
Filed:
Oct 31, 2000
Appl. No.:
09/703233
Inventors:
Fortuna Haviv - Deerfield IL
Jack Henkin - Highland Park IL
Douglas M. Kalvin - Buffalo Grove IL
Michael F. Bradley - Wadsworth IL
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
C07K 700
US Classification:
530328, 514 15
Abstract:
N-Alkylated peptides of formula (I) are useful for inhibiting angiogenesis. Also disclosed are angiogenesis-inhibiting compositions and methods of inhibiting angiogenesis in a mammal.

Di-, Tri-, And Tetra-Peptides Having Antiangiogenic Activity

View page
US Patent:
7001984, Feb 21, 2006
Filed:
Oct 30, 2002
Appl. No.:
10/284227
Inventors:
Fortuna Haviv - Deerfield IL, US
Michael F. Bradley - Wadsworth IL, US
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
C07K 5/10
US Classification:
530330, 530331, 514 18
Abstract:
Compounds having the formula (SEQ ID NO:1), which are useful for treating conditions that arise from or are exacerbated by angiogenesis, are described. Also disclosed are pharmaceutical compositions comprising these compounds, methods of treatment using these compounds, and methods of inhibiting angiogenesis.

Tri-, Tetra-, And Penta-Peptides Having Antiangiogenic Activity

View page
US Patent:
7037897, May 2, 2006
Filed:
Oct 30, 2002
Appl. No.:
10/283813
Inventors:
Fortuna Haviv - Deerfield IL, US
Michael F. Bradley - Wadsworth IL, US
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
A61K 38/00
US Classification:
514 17, 514 16, 530329
Abstract:
Compounds of formula (SEQ ID NO:1), which are useful for treating conditions that arise from or are exacerbated by angiogenesis, are described. Also disclosed are pharmaceutical compositions comprising these compounds, methods of treatment using these compounds, and methods of inhibiting angiogenesis.

Hepta-, Octa-And Nonapeptides Having Antiangiogenic Activity

View page
US Patent:
7067490, Jun 27, 2006
Filed:
Oct 30, 2002
Appl. No.:
10/283550
Inventors:
Fortuna Haviv - Deerfield IL, US
Michael F. Bradley - Wadsworth IL, US
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
A61K 38/08
C07K 7/06
US Classification:
514 15, 514 16, 530328, 530329
Abstract:
Compounds of formula (SEQ ID NO:1), which are useful for treating conditions that arise from or are exacerbated by angiogenesis, are described. Also disclosed are pharmaceutical compositions comprising these compounds, methods of treatment using these compounds, and methods of inhibiting angiogenesis.
Control profile
Fortuna Haviv from Deerfield, IL, age ~84 Get Report